Emerging evidence suggests human amnion tissue as a valuable source of two distinct
types of pluripotent cells, amnion epithelial cells (hAECs) and mesenchymal stromal cells …

Background aims. Emerging evidence suggests human placental membrane is a valuable
source of mesenchymal stromal cells (MSC). Amnion and chorion are tissues of early …

Abstract Background Mesenchymal stromal cells (MSCs) are currently being evaluated in
numerous pre-clinical and clinical cell-based therapy studies. Furthermore, there is an …

Mesenchymal stem cells (MSCs) have the ability to differentiate into osteocytes,
chondrocytes, and adipocytes and possess immunomodulatory properties. Amniotic …

Stem cells isolated from amniotic fluid are known to be able to differentiate into different cells
types, thus being considered as a powerful tool for cellular therapy of different human …

Introduction: The human amniotic membrane is a highly abundant and readily available
tissue that may be useful for regenerative medicine and cell therapy. Aim: To compare two …

Over the past decade, there has been ever‐increasing emphasis placed on stem cells and
their potential role in regenerative medicine for reconstruction of bio‐artificial tissues and …

The human amniotic membrane (HAM) contains two cell types from different embryological
origins. Human amnion epithelial cells (hAECs) are derived from the embryonic ectoderm …

Background Mesenchymal stromal cells are multipotent cells considered to be of great
promise for use in regenerative medicine. However, the cell dose may be a critical factor in …

The amnion membrane is developed from embryo-derived cells, and amniotic cells have
been shown to exhibit multidifferentiation potential. These cells represent a desirable source …